Pharmaceutical manufacturing

A worker wearing a protective suit stands in front of an electronic display board in the lobby of the Shanghai Stock Exchange building in Shanghai, Monday, Feb. 3, 2020. The Shanghai Composite index tumbled 8.7% Monday then rebounded slightly as Chinese regulators moved to stabilize markets reopening from a prolonged national holiday despite a rising death toll from a new virus that has spread to more than 20 countries. (AP Photo)
February 03, 2020 - 6:51 am
BANGKOK (AP) — China's main stock index tumbled nearly 8% Monday as the country's markets reopened and regulators sought to calm investors over the impact of a virus that has spread to more than 20 countries and killed more than 360 people. Other markets, including in Europe and Wall Street futures...
Read More
FILE - In this Nov. 23, 2015, file photo, the Pfizer logo is displayed at world headquarters in New York. Pfizer is reporting a $306 million loss for the fourth quarter after it shifted its consumer health business into a joint venture last year. It narrowly Wall Street expectations for net income when nonrecurring events are removed. The biggest US drugmaker on Tuesday, Jan. 28, 2020 reported a net loss of 6 cents per share. (AP Photo/Mark Lennihan, File)
January 28, 2020 - 3:31 pm
Pfizer's ongoing restructuring is significantly reducing revenue, resulting in a $337 million loss in its fourth quarter and a miss of Wall Street's profit expectations. The results and Pfizer's 2020 financial forecasts didn't please investors, who drove Pfizer shares down more than 4%, an...
Read More
FILE - In this Aug. 4, 2017, file photo, Martin Shkreli leaves federal court in New York while on trial for deceiving investors in a pair of failed hedge funds. On Monday, Jan. 27, 2020, New York state and federal authorities sued the imprisoned Shkreli, also known as "Pharma Bro," over business tactics that helped make him the bad-boy face of profiteering in pharmaceuticals, seeking to bar him from the industry for life. (AP Photo/Seth Wenig, File)
January 27, 2020 - 7:27 pm
NEW YORK (AP) — State and federal authorities sued imprisoned entrepreneur Martin Shkreli on Monday over tactics that shielded a profitable drug from competition after a price hike made the so-called “Pharma Bro” infamous. Shkreli was scorned as the bad-boy face of pharmaceuticals profiteering...
Read More
January 25, 2020 - 10:25 am
NEW YORK (AP) — Stocks around the world fell this week on worries that a new type of virus in China may ultimately hit profits for companies from Wuhan to Washington. The World Health Organization has held off on calling the outbreak a global health emergency but says it may become one. The virus...
Read More
FILE - In this Jan. 9, 2020, file photo specialist Brian Giannettino works on the floor of the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Friday, Jan. 24. (AP Photo/Richard Drew, File)
January 24, 2020 - 4:03 pm
Health care companies led a broad slide in U.S. stocks Friday as increased fears over the spread of a deadly outbreak of coronavirus rattled markets. The S&P 500 had its worst day since early October and snapped a two-week winning streak. The sell-off followed news that a Chicago woman has...
Read More
French President Emmanuel Macron delivers a speech as he visits a plant of British-Swedish pharmaceutical group Astrazeneca in Dunkirk, northern France, Monday, Jan. 20, 2020. French President Emmanuel Macron is hosting 180 international business leaders later today at the Palace of Versailles in a bid to promote France's economic attractiveness despite over six weeks of crippling strikes over his government's planned pension changes.(Denis Charlet/Pool Photo via AP)
January 20, 2020 - 9:00 am
PARIS (AP) — France's president is taking on the role of salesman in chief for his strike-battered country. Emmanuel Macron used the splendor of the Palace of Versailles to woo international business leaders on Monday, insisting that his reforms are attracting investors despite six weeks of...
Read More
Democratic presidential candidate South Bend Mayor Pete Buttigieg speaks during a Democratic presidential primary debate Thursday, Dec. 19, 2019, in Los Angeles. (AP Photo/Chris Carlson)
December 21, 2019 - 12:01 pm
WASHINGTON (AP) — The financial sector, blamed by progressives for spawning the 2008 economic collapse, is lining up behind Pete Buttigieg’s presidential campaign. The mayor of South Bend, Indiana, has collected more campaign cash from donors and political action committees tied to the financial,...
Read More
FILE - This June 15, 2018, file photo shows pharmaceuticals in North Andover, Mass. A revamped North American trade deal is nearing passage in Congress, giving both the White House and House Democrats cause to claim victory. There is relief, too, for farmers and businesses that wanted clearer rules governing the vast flow of goods among the United States, Canada and Mexico. But the pact left at least one surprising loser: The pharmaceutical industry, a near-invincible lobbying powerhouse in Washington. (AP Photo/Elise Amendola, File)
December 19, 2019 - 3:43 pm
A revamped North American trade deal nearing passage in Congress gives both the White House and Democrats a chance to claim victory and offers farmers and businesses clearer rules governing the vast flow of goods among the United States, Canada and Mexico. But the pact leaves at least one...
Read More
This image provided by Sarepta Therapeutics in December 2019 shows a box and vial of their drug Vyondys 53. On Thursday, Dec. 12, 2019, U.S. health regulators said they approved this second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months earlier. (Sarepta Therapeutics via AP)
December 13, 2019 - 1:28 pm
WASHINGTON (AP) — U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago. The ruling marks the second time the Food and Drug Administration has granted preliminary...
Read More
December 06, 2019 - 8:10 pm
WASHINGTON (AP) — A bipartisan Senate bill to curb prescription drug costs for Medicare recipients got a makeover Friday to lower copays and make it easier for seniors to budget for their expenses. The updated legislation unveiled by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., would lower...
Read More

Pages